Provided by Tiger Trade Technology Pte. Ltd.

The Oncology Institute

6.47
-0.0750-1.15%
Post-market: 6.600.1350+2.09%19:42 EDT
Volume:1.53M
Turnover:9.99M
Market Cap:658.89M
PE:-21.25
High:6.75
Open:6.59
Low:6.37
Close:6.54
52wk High:7.05
52wk Low:2.32
Shares:101.92M
Float Shares:88.60M
Volume Ratio:1.34
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3042
EPS(LYR):-0.5445
ROE:--
ROA:-9.65%
PB:-26.45
PE(LYR):-11.87

Loading ...

Company Profile

Company Name:
The Oncology Institute
Exchange:
NASDAQ
Establishment Date:
2007
Employees:
641
Office Location:
18000 Studebaker Road,Suite 800,Cerritos,California,United States
Zip Code:
90703
Fax:
- -
Introduction:
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates in three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient blood product transfusions, and patient support services. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Directors

Name
Position
Brad Hively
Vice Chairman of the Board
Daniel Virnich
Director, President and Chief Executive Officer
Anne McGeorge
Chair
Karen M. Johnson
Independent Director
Kimberly Tzoumakas
Independent Director
Mark L. Pacala
Independent Director
Mohit Kaushal
Independent Director

Shareholders

Name
Position
Daniel Virnich
Director, President and Chief Executive Officer
Robert Ross Carter
Chief Financial Officer and Principal Accounting Officer
Yale Podnos
Chief Medical Officer